CA-125: a biomarker put to the test

Charlie Schmidt, Schmidt C
Journal of the National Cancer Institute · 2011 · vol. 103(17) , pp. 1290–1 · doi:10.1093/jnci/djr344 · PMID:21852262
Other OA: bronze public-domain-us
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-12 ⓘ

This review evaluates the clinical utility of CA-125 as a biomarker for ovarian cancer detection, monitoring, and prognosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Biomarkers, Tumor CA-125 Antigen Mass Screening Ovarian Neoplasms Ovarian Neoplasms Biomarkers Biomarkers Biomarkers Biomarkers, Tumor Biomarkers, Tumor CA-125 Antigen CA-125 Antigen Clinical Trials as Topic Clinical Trials as Topic Endometriosis Endometriosis Endometriosis False Positive Reactions False Positive Reactions Female

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-11-08T09:52:27.483963+00:00
pubmed
last seen: 2026-10-08T21:09:19.025198+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine